Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Velaglucerase alfa

EU orphan designation number: EU/3/10/752   
Active ingredient: Velaglucerase alfa
Indication: Treatment of Gaucher disease
Sponsor: Shire Pharmaceuticals Ireland Limited
Block 2-3 Miesian Plaza, 50-58 Baggot Street Lower, Dublin 2, Ireland
EU Centralised marketing authorisation: A centralised EU marketing authorisation has been obtained under the name VPRIV on 26/08/2010 with the number EU/1/10/646

   Public summary of scientific opinion     EPAR

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/06/2010 Orphan designation EMEA/OD/140/09 (2010)3833 of 9/06/2010
6/11/2017 Change of name and/or address of sponsor